Description
A cell permeable, competitive, and reversible inhibitor of cGKs that blocks activation of cGKI and cGKII by cGMP (Kis = 35 and 30 nM); less potently inhibits PKA (Ki = 11 µM) and cGMP-induced activation of cyclic nucleotide-gated channels (IC50 = 25 µM); resistant to hydrolysis by PDE11
Formal name: 2-bromo-3,4-dihydro-3-[3,5-O-[(R)-mercaptophosphinylidene]-β-D-ribofuranosyl]-6-phenyl-9H-imidazo[1,2-a]purin-9-one, monosodium salt
Synonyms: Rp-8-bromo-PET-cGMPS
Molecular weight: 562.3
CAS: 185246-32-6
Purity: ≥99%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors||Product Type|Biochemicals|Receptor Pharmacology|Agonists||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cell Biology|Cell Signaling|cGMP Signaling